Registration opens for the Summer School in Surgical Data Science 2024 (EDU4SDS)

Registration opens for the Summer School in Surgical Data Science 2024 (EDU4SDS)

Feb 19, 2024 | Education, Event

IHU Strasbourg, in partnership with the University of Strasbourg, is launching the third edition of its Surgical Data Science Summer School. Clinicians and engineers work closely together on practical as well as moonshot research ideas to improve the safety and efficiency of surgical procedures by exploiting multimodal data and artificial intelligence algorithms.

EDU4SDS - Ouverture des inscriptions 2024

Since its launch in 2022, the event has met with growing success, attracting participants from all over the world. Scheduled to take place from July 15 to 19, 2024, this edition features an intensive five-day program of lectures, hands-on work and group projects.

Following the success of previous editions, this year’s promises to be an even more enriching experience, offering participants the opportunity to collaborate with renowned experts and deepen their knowledge in this exciting field.

Registration opened on January 1, 2024, with an application deadline of April 15, 2024. The registration fee is €300 for students, covering online training modules and face-to-face sessions at IHU Strasbourg.

We strongly encourage medical students, residents, computer scientists and engineers to register now:

logo_EDU4SDS

Online registration and modules: https://edu4sds.eve-evolving-education.eu/
Event website: https://www.edu4sds.org/

Don’t miss this unique opportunity to take part in cutting-edge training in surgical data science.

Join us for this immersive and collaborative experience!

Launch of the MEDITWIN Consortium: Virtual twins revolutionize medical practice

Launch of the MEDITWIN Consortium: Virtual twins revolutionize medical practice

Dec 18, 2023 | Innovation

The MEDITWIN consortium was officially announced on December 11, 2023, in the presence of the French President and renowned partners such as Dassault Systèmes, seven University Hospital Institutes, Nantes University Hospital, Inria, and associated startups. MEDITWIN aims to introduce personalized virtual twins for organs, metabolism and cancer tumors to improve diagnosis and medical care. This ambitious project will be detailed at the PariSanté Campus event on Thursday December 14, in the presence of Industry Minister Roland Lescure.

The MEDITWIN project will focus on seven new medical practices in the fields of neurology, cardiology and oncology, with the creation of seven “virtual health products“. These advances will be deployed on a sovereign industrial cloud platform. Drawing on the global expertise of its partners, including Dassault Systèmes, Nantes University Hospital, and startups such as inHEART, Codoc, Qairnel, and Neurometers, MEDITWIN is building on the success of virtual twins in other industries to revolutionize healthcare.

The five-year project (2024-2029) will receive financial support from the French government as part of France 2030. MEDITWIN aims to industrialize, clinically validate and standardize the use of virtual twins in the medical field. These advances promise to improve the efficiency of care, the quality of multidisciplinary decisions, and the effectiveness and safety of medical practices and interventions. By establishing standards of care in the form of virtualized experiences, MEDITWIN aspires to become a global benchmark for quality of care and to foster advances in medical science.

Prof. Didier Mutter, CEO, IHU Strasbourg
« Digital twins will be essential elements in the medicine of the future, as they will enable treatments to be simulated in order to provide patients with the most beneficial results possible. MEDITWIN is an extraordinary project in terms of its ambition and the challenges to be met, and it’s also a first for the IHU France alliance to bring together on the same project a multidisciplinary biomedical research power unrivalled anywhere in the world. For the IHU Strasbourg, it will be a powerful powerful boost to improve for improving the minimally invasive management of metastatic colorectal cancer, in close collaboration with two of its historical founders, Inria and the University Hospitals of Strasbourg. »

Read the press release of 11/12/2023 (in French): https://www.3ds.com/fr/newsroom/press-releases/meditwin-launch

Taurus Endoscopy raises €2.5M seed to advance endoluminal closure

Taurus Endoscopy raises €2.5M seed to advance endoluminal closure

Nov 16, 2023 | Research

Taurus Endoscopy, an IHU spin-off specializing in innovative solutions for unmet needs in flexible digestive endoscopy, announces that it has raised €2.5M in venture capital from the French fund MEDEVICE Capital and the U.S. fund Santé Ventures.

Taurus Endoscopy develops solutions for bleeding and flexible endoscopic gastrointestinal closure. At the heart of the technology is an implantable clip with an innovative design resulting from work carried out by the IHU Strasbourg innovation team. “This fundraising will allow Taurus Endoscopy to bring its first product, Taurus 1, to the market and to continue the development of pipeline products for closure in endoluminal interventions. At MEDEVICE, we are convinced that Taurus will be able to bring significant innovation to the market of endoscopic clips, therefore enhancing patient outcomes for the growing number of surgical procedures it addresses” said Cécile Real, Co-founder and CEO of MEDEVICE Capital.

The company was also a 2023 Grand Prix winner of the French national i-Lab competition, organized by the Ministry of Higher Education, Research and Innovation in partnership with BPI France.

HUS Technical sequencing at IHU Strasbourg: a world first in neoplastic diseases

HUS Technical sequencing at IHU Strasbourg: a world first in neoplastic diseases

Nov 15, 2023 | Medical first

At the IHU Strasbourg, Prof. Anne Olland and Prof. Pierre-Emmanuel Falcoz, of the Thoracic Surgery and Lung Transplant Department at the University Hospitals in Strasbourg, performed a ground-breaking technical sequencing on Thursday 26 October, benefiting from the institute’s specialty in image-guided minimally invasive robot-assisted surgery.

For the first time, the technical sequencing took place entirely on site, around the patient, who did not need to be transported from one examination to the next. This sequence enabled precise minimally invasive (robot-assisted surgery) and parenchymal sparing (controlled segmentectomy). This surgery offers greater precision and reliability in the early stages of neoplastic disease. The world-first sequencing also expands the IHU Strasbourg’s specialty domains, historically linked to digestive surgery.

This work was the fruit of close multidisciplinary collaboration with IBODEs, radio manipulators, intensive care anaesthetists, as well as interventional radiologists, management teams and industry representatives.

Innovation

The offer of precise, reliable surgery on early-stage neoplastic disease: imaging as close as possible to the surgical procedure enables accurate 3-dimensional reconstruction on a CT scan performed on a patient who is already asleep and in the operating position at the time of surgery, with no positional shift and no lag in the evolution of the disease with a CT scan performed on the same day (compared with a CT scan usually performed lying down, with a lag of one to several days or even weeks in relation to the surgical procedure). The technical sequence takes place around the patient, who does not need to be transported from one examination to the next, enabling precise, minimally invasive, parenchymal-sparing surgery. This technical development remains linked to the HUS’s cross-disciplinary lung cancer research programs.

Prof. Christian DEBRY nominated as new CEO of the IHU Strasbourg

Prof. Christian DEBRY nominated as new CEO of the IHU Strasbourg

Nov 8, 2023 | Agenda, Event, News, VIP

Christian DEBRY, 62, University Professor and hospital practitioner at Strasbourg University Hospitals (HUS), has been appointed Chief Executive Officer of the IHU Strasbourg, which specializes in image-guided minimally invasive surgery. Professor DEBRY will take up his post on 1 January 2024, for a 4-year term, replacing Professor Didier MUTTER, whose appointment expires on 31 December 2023. Professor DEBRY is Head of the ENT and Cervico-facial Surgery Department and Head of the Head and Neck Unit at the Strasbourg University Hospital. He is a member of Inserm “Biomaterials and Bioengineering” Unit 1121, and Vice-Dean of the Strasbourg Faculty of Medicine, in charge of international relations. He has extensive experience in translational research in the field of medical technologies, and has founded several start-ups. The international selection panel underlined Professor DEBRY’s extensive international experience and his skills in research and innovation, which will be essential assets for the future of the IHU Strasbourg.

About the IHU Strasbourg

The IHU Strasbourg was created in 2011 under the aegis of Professor Jacques Marescaux. It is a multidisciplinary institute dedicated to the development and dissemination of image-guided minimally invasive surgery, with a high level of precision and safety, with patient benefit being the highest priority. The IHU Strasbourg’s programmes focus on combining the most advanced interventional techniques, harnessing artificial intelligence to guide the overall surgical process, and taking into account the entire care pathway to guarantee the positive impact of innovations for patients and society. The IHU Strasbourg is supported by public and private founders, and is positioned as a network leader for the development of minimally invasive therapies, with a dynamic approach that systematically integrates care, research, training, and commercialisation. Its transfer model is based on accelerating the development of discoveries to commercial maturity through rapid clinical evaluation, and it favours the creation of companies to create specialised jobs in a cutting-edge sector in which France aims to be a leader.